These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 16340628)
1. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628 [TBL] [Abstract][Full Text] [Related]
2. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes. Domingues GR; Moraes-Filho JP; Domingues AG Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538 [TBL] [Abstract][Full Text] [Related]
3. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico. Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888 [TBL] [Abstract][Full Text] [Related]
4. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)]. Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061 [TBL] [Abstract][Full Text] [Related]
5. 24 Versus 48-hour bravo pH monitoring. Chander B; Hanley-Williams N; Deng Y; Sheth A J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323 [TBL] [Abstract][Full Text] [Related]
6. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease]. Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980 [TBL] [Abstract][Full Text] [Related]
9. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center. Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281 [TBL] [Abstract][Full Text] [Related]
10. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials. Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638 [TBL] [Abstract][Full Text] [Related]
11. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years. Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233 [TBL] [Abstract][Full Text] [Related]
12. [Outpatient monitoring of oesophageal pH with a catheter-free pH-meter (Bravo System). A Study of tolerance, safety and efficacy]. Martínez de Haro LF; Munitiz V; Ortiz A; Ruiz de Angulo D; Navarro MD; Parrilla P Cir Esp; 2008 Oct; 84(4):201-9. PubMed ID: 18928770 [TBL] [Abstract][Full Text] [Related]
14. Tolerability and clinical utility of the Bravo pH capsule in children. Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903 [TBL] [Abstract][Full Text] [Related]
15. Two years' experience of using the Bravo wireless oesophageal pH monitoring system at a single UK tertiary centre. Rao NM; Campbell DI; Rao P Acta Paediatr; 2017 Feb; 106(2):312-315. PubMed ID: 27862298 [TBL] [Abstract][Full Text] [Related]
16. Wireless capsules for esophageal pH monitoring: are we placing them correctly? Doma S; Paladugu S; Parkman HP; Friedenberg FK Digestion; 2010; 82(1):54-9. PubMed ID: 20215751 [TBL] [Abstract][Full Text] [Related]
17. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]
18. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare? Bechtold ML; Holly JS; Thaler K; Marshall JB World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227 [TBL] [Abstract][Full Text] [Related]
19. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading. Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392 [TBL] [Abstract][Full Text] [Related]
20. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring. Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]